Previous Close | 66.52 |
Open | 67.83 |
Bid | 68.61 x 900 |
Ask | 68.73 x 1100 |
Day's Range | 66.14 - 68.81 |
52 Week Range | 64.13 - 110.45 |
Volume | |
Avg. Volume | 3,804,550 |
Market Cap | 24.487B |
Beta (5Y Monthly) | 1.65 |
PE Ratio (TTM) | 6.03 |
EPS (TTM) | 11.41 |
Earnings Date | Apr 20, 2022 - Apr 25, 2022 |
Forward Dividend & Yield | 0.90 (1.31%) |
Ex-Dividend Date | May 06, 2022 |
1y Target Est | 106.32 |
Though the broader market volatility has presented intriguing, discounted opportunities, some ideas are simply stocks to avoid. Novavax (NVAX) — A huge winner during the height of the coronavirus pandemic, the resultant societal fatigue makes NVAX too risky for conservative investors. Teladoc Health (TDOC) — While TDOC has given up all of its post-pandemic gains and then some, the lack of current relevance hurts the telehealth sector. GrowGeneration (GRWG) — Unfortunately, the black market for “
Weakness and long-term fear make investing in value stocks a strong idea right now. Target (TGT): Earnings have been strong and Target is fundamentally strong. D.R. Horton (DHI): Forces are in place for this home builder to continue to perform very well. Deere (DE): Has plenty of tailwinds as well as built-in upside. AbbVie (ABBV): Increased guidance and rock-solid dividend make AbbVie a buy. Berkshire Hathaway (BRK-A, BRK-B): The value investing world will always consider the ever reliable Berk
Bank of America's outlook for housing this year is mixed, estimating both higher prices and strong demand.